Table 2: New onset Atrial Tachyarrhythmia
COVID+ n = 32 COVID+ n = 32 COVID- n = 19
HC n=18 Stable n=14
p Value*
Stable n=19
p Value
Age (years) 64 ± 15 62 ± 12 0.63 64 ± 15 0.92
BMI (kg/m2) 30 ± 8 27 ± 6 0.27 27 ± 7 0.24
Male 11 (61%) 10 (71%) 0.54 12 (63%) 0.90
White 9 (50 %) 8 (57%) 0.69 11 (58%) 0.63
Past Medical History Past Medical History Past Medical History Past Medical History Past Medical History Past Medical History
Hypertension 14 (78%) 9 (64%) 0.40 13 (68%) 0.19
Systolic HF 2 (11%) 3 (21%) 0.43 5 (26%) 0.24
Diastolic HF 2 (11%) 4 (29%) 0.21 9 (47%) 0.02
Coronary Artery Disease 2 (11%) 3 (21%) 0.43 8 (42%) 0.03
Atrial Fibrillation 1 (6%) 3 (21%) 0.18 5 (26%) 0.09
Diabetes 10 (56%) 4 (29%) 0.13 6 (32%) 0.14
COPD 3 (17%) 2 (14%) 0.85 7 (37%) 0.17
Echocardiography Echocardiography Echocardiography Echocardiography Echocardiography Echocardiography
LVEF 55 ± 14 58 ± 10 0.62 44 ± 17 0.07
Diastolic Dysfunction 4 (22%) 3 (30%) 0.78 11 (92%) 0.0001
LVIDd 4.7 ± 0.8 4.9 ± 0.3 0.41 5.3 ± 1.4 0.16
RV Dysfunction 5 (28%) 1 (10%) 0.21 1 (10%) 0.21
TAPSE 2.0 ± 0.4 2.2 ± 0.5 0.38 2.0 ± 0.4 0.96
LA Dilation 2 (11%) 2 (25%) 0.65 3 (27%) 0.54
Mitral Regurgitation 3 (17%) 4 (29%) 0.42 5 (26%) 0.48
Tricuspid Regurgitation 5 (28%) 6 (43%) 0.37 7 (37%) 0.56
Aortic Regurgitation 2 (11%) 0 0.20 4 (21%) 0.41
Pericardial Effusion 4 (22%) 3 (21%) 0.96 3 (16%) 0.62
Vital Signs and Laboratory Values at ATA Onset Vital Signs and Laboratory Values at ATA Onset Vital Signs and Laboratory Values at ATA Onset Vital Signs and Laboratory Values at ATA Onset Vital Signs and Laboratory Values at ATA Onset Vital Signs and Laboratory Values at ATA Onset
Heart Rate Change 50 ± 22 35 ± 24 0.09 39 ± 25 0.18
MAP 74 ± 16 89 ± 10 0.004 82 ± 15 0.12
Sodium 140 ± 6 137 ± 5 0.34 138 ± 8 0.49
Potassium 4.5 ± 0.4 4.2 ± 0.5 0.04 4.1 ± 0.6 0.02
Magnesium 2.0 ± 0.4 2.2 ± 0.4 0.21 2.0 ± 0.5 0.99
Creatinine 2.2 ± 1.4 1.8 ± 0.8 0.46 2.2 ± 2.4 0.90
Inpatient Therapies at ATA Onset Inpatient Therapies at ATA Onset Inpatient Therapies at ATA Onset Inpatient Therapies at ATA Onset Inpatient Therapies at ATA Onset Inpatient Therapies at ATA Onset
Mechanical Ventilation 18 (100%) 8 (57%) 0.002 3 (16%) 0.0001
Prone Positioning 2 (11%) 0 0.20 0 0.14
Vasopressors Use 15 (83%) 3 (21%) 0.0001 2 (11%) 0.0001
CRRT 9 (50%) 4 (29%) 0.22 4 (21%) 0.07
Ventilation Parameters at ATA Onset Ventilation Parameters at ATA Onset Ventilation Parameters at ATA Onset Ventilation Parameters at ATA Onset Ventilation Parameters at ATA Onset Ventilation Parameters at ATA Onset
PEEP 10 ± 4 5 ± 4 0.005 1 ± 3 0.0001
Plateau Pressure 25 ± 7 23 ± 5 0.58 27 ± 4 0.75
FiO2 (%) 57 ± 17 46 ± 15 0.06 29 ± 6 0.0001
Outcomes Outcomes Outcomes Outcomes Outcomes Outcomes
Death 12 (67%) 4 (29%) 0.03 5 (26%) 0.01